<!DOCTYPE html>
<html>
<head>


<title>EP related Guidelines Review '18 to mid '19</title>

<!-- Global site tag (gtag.js) - Google Analytics -->
<!-- Global site tag (gtag.js) - Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-119340815-15"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'UA-119340815-15');
</script>




</script>

</head>

<meta name="viewport" content="width=device-width, initial-scale=1">
<meta charset="UTF-8">

<link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">
<link href="https://fonts.googleapis.com/css?family=Poppins|Open+Sans+Condensed:300,700|Open+Sans" rel="stylesheet">
<link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.8.1/css/all.css" integrity="sha384-50oBUHEmvpQ+1lW4y57PTFmhCaXp0ML5d60M1M7uH2+nqUivzIebhndOJK28anvf" crossorigin="anonymous">


<style>

.darkGrey {background-color:#2A1B3D}
.grey {color:#a4b3b6}
.greyBg {background-color:#a4b3b6}
.pink {color:#de91a2}
.pinkBg {background-color:#de91a2}
.blue {color:#9bb7ee}
.blueBg {background-color:#9bb7ee}
.purple {color:#b48ce6}
.purpleBg {background-color:#b48ce6}

.san {font-family: 'Open Sans', sans-serif;}
.openSans {font-family: 'Open Sans Condensed', sans-serif;}
.ring {font-weight: 700;}
.ring :hover {text-shadow: rgba(99, 99, 99, 0.6) 5px -5px 7px}

.mobileOnly {display: none}
@media only screen and (max-width: 600px) {
    .noMobile {display:none}
    .mobileOnly {display: block}
}

.pointer {
    cursor: pointer;
    height: 0.5em;
    width: 0.5em;
    background-color: #fc553d;
    border-radius: 50%;
    position: fixed;  
    z-index: 1;
    animation: blink 1.5s linear infinite;
    }
    @keyframes blink{
    0%{opacity: 0;}
    50%{opacity: 0.7}
    100%{opacity: 1;}
    }

#menu {display: none}
.menuItem {font-family: 'Open Sans Condensed', sans-serif;color:#555;font-size: 1.8vmax;
vertical-align: middle;}
.showOnClick {display: none}

.fadeIn {animation: unfade 2s 1 linear;}
@keyframes fade {
    0% {opacity: 1.0}   
    100% {opacity: 0.3}
}
@keyframes unfade {
    0% {opacity: 0.3}
    100% {opacity: 1.0}
}

.bigHeader {font-family: 'Open Sans Condensed', sans-serif;font-size: 7vmax;padding: 20vh 20vw;font-weight: 700;
color:#2a1b3d;height:100vh;line-height: 120%}
.smallHeader{font-size: 4vmax;line-height: 100%;font-family: 'Open Sans Condensed', sans-serif;font-weight: 700;
padding:1vmax}

@media only screen and (max-width: 600px) {
   .bigHeader{padding: 10vmax;font-size:5vmax;height: fit-content}
}

#brady0,#brady1,#brady2,#brady3,#show3,#show4,#show5,#show6,#show7 {display: none;}

.animateBg {animation: bgSize 1.5s 1 linear}
@keyframes bgSize {
    0% {background-size: 0%}
    100% {background-size: 100%}
}

.block {min-height:100vh}
.pad20Center {padding: 20vh 22vw}
.pad10LR {padding: 2vmax 10vw}
@media only screen and (max-width: 800px) {
   .pad20Center{padding: 10vmax 1.5vmax}
   .block {height:fit-content}
   #show3,#show4,#show5,#show6,#show7 {display: block}
   #card {height:30vh}
}

.ref{font-family: 'Open Sans', sans-serif;font-size:1vmax;color:#878787;font-weight:400}

.shaggyPink {border-bottom: 0.5vmax solid transparent;border-image: url('underlinePink.png') 40 stretch;
      border-top: 0.5vmax solid transparent;border-image: url('underlinePink.png') 40 stretch;
      }

#card {font-size:3vmax;height: 50vh;padding:2vmax;display: table-cell;vertical-align: middle;width:80vw;
        box-shadow: rgba(200,200, 200, 0.6) 5px -5px 3px}
.sCard {padding:2vmax;box-shadow: rgba(200,200, 200, 0.6) -5px -5px 3px}

</style>
<body>

<!--front page-->
<div id="top" class="darkGrey block" style="height:100vh;">
    <div id="mainTitle" class="openSans w3-center" style="font-size: 6vmax;padding-top:12vh;color:white;font-weight: 300">
        EP-related Guidelines Review
    </div>
    <div class="w3-cell-row w3-center" id="ringRow" style="padding-top:5vh;" >
        <div class="w3-col s4 m3 l2 w3-center openSans pink ring" style="background:url(ringPink.png);font-size:2vmax;background-size: 100%;background-repeat: no-repeat">
            <a href="#brady" style="text-decoration:none">
            Bradycardia <br><span style="font-size:1.7vmax;">& conduction delay </span></a>
        </div>
        <div class="w3-col s4 m3 l2 w3-center openSans blue ring" style="background:url(ringBlue.png);background-size: 100%;background-repeat: no-repeat;
        font-size:4vmax">
            <a href="#af" style="text-decoration:none">AF</a>
        </div>
        <div class="w3-col s4 m3 l2 w3-center openSans purple ring" style="background:url(ringPurple.png);background-size: 100%;background-repeat: no-repeat;
        font-size:2vmax">
            <a href="#asym" style="text-decoration:none">Asymptomatic Arrhythmias</a>
        </div>
    </div>
    <div class="w3-center openSans w3-margin" style="font-size:2.5vmax;color:white;line-height: 100%;padding: 1.5vmax">
        <div id="author"></div>
        <div id="title"></div>
    </div>

    
    <div class="w3-center w3-padding" style="margin-top: 1.5vh">
        <a href="https://www.facebook.com/HeartRhythmBox" class="san grey" target="_blank" 
            style="font-size: 1.5vmax;text-decoration: none">
                <i class="fab fa-facebook-square" style="font-size:1.5vmax;"></i>
                HeartRhythmBox
            </a>
    </div>

</div>

<!--menu-->
<div class="w3-bar w3-top" id="menu">
    
<div class="w3-bar-item w3-button w3-round-large menuItem w3-padding-small w3-animate-opacity" onclick="openMenu()">
    <i class="fas fa-bars" style="vertical-align: middle;"></i>
</div>
<div class="w3-bar-item w3-button w3-round-large menuItem w3-padding-small">
    <a href="#top" style="text-decoration:none" class="showOnClick w3-animate-left">
    Top</a>
</div>
<div class="w3-bar-item w3-button w3-round-large menuItem w3-padding-small">
    <a href="#brady" style="text-decoration:none" class="showOnClick w3-animate-left">
    brady</a>
</div>
<div class="w3-bar-item menuItem w3-button w3-round-large w3-padding-small">
    <a href="#af" style="text-decoration:none" class="showOnClick w3-animate-left">
    AF</a></div>
<div class="w3-bar-item menuItem w3-button w3-round-large w3-padding-small">
    <a href="#asym" style="text-decoration:none" class="showOnClick w3-animate-left">
    Asymp</a></div>


</div>

<!--start pointer-->
<div onclick="pointer()"><span class="pointer" style="display: none"></span> 

<!--bradycardia title-->
<div id='brady' class="block darkGrey">
    <a href="http://www.onlinejacc.org/guidelines/bradycardia" target="_blank" style="text-decoration:none">
    <div class="w3-row pad20Center">
        
        <div class="w3-cell openSans w3-center w3-cell-middle" style="background:url('ringSolidPink.png') center no-repeat;background-size: contain;
        font-size:1.8vmax;line-height: 110%;padding: 1vmax;color:#2A1B3D">
            2018<br>ACC/AHA/HRS
        </div>
        <div class="w3-cell openSans w3-padding pink" style="font-size:5vmax;font-weight:700;line-height: 110%">
            Bradycardia and Cardiac Conduction Delay
        </div>
    </div></a>
</div>

<!--Osa-->
<div class="block pinkBg">
    <div id='bigH0' class="bigHeader noMobile" onclick="splitScreen('bigH0','brady0','fChild0')" style="cursor:pointer" title="click me">
        Look for Sleep Apnea in patients with bradycardia
        <div style="font-size:2vmax;font-weight:400;line-height:120%;color:#878787">
            click for more...</div>
    </div>
    
    <!--l10 m9 s12-->
    <div id='brady0' class="w3-row w3-padding smallHeader" style="padding-top:2vmax;">
        <div id='fChild0' class="w3-col animateBg l2 m3 noMobile w3-center grey" 
        style="background:url('ringSolidDark.png') no-repeat center;background-size: cover;">
        Sleep<br>Apnea</span>
        </div>
        <div class="w3-col s12 mobileOnly bigHeader" style="border-bottom:#2a1b3d  solid 1vmax">
            Look for Sleep Apnea in patients with bradycardia
        </div>
        <div class="w3-col l10 m9 s12 openSans w3-padding fadeIn">
            <div class="noMobile" style="height:25vh"></div>
            <ul class="w3-ul" style="font-size: 2.8vmax;font-weight:400;border:#2a1b3d solid 0.1vmax;
            padding: 0.5vmax 1vmax">
                <li>Profound bradycardia can be found in Up to 1/3 of patients with OSA.</li>
                <li>OSA leads to many CV consequences. </li>
                <li>Treating OSA reduces arrhythmias and improves CV outcomes.</li>
                <li class="darkGrey grey" style="font-weight: 700">
                    Screening and Treating OSA in patients with bradycardia and in those who already had
                    pacemaker are recommended (class I & IIa).
                </li>
            </ul>
        </div>
        </div> 

    <!--mobile-->
    <div class="w3-row mobileOnly">
        <div class="w3-col s12 mobileOnly bigHeader"
        style="background:url('ringPink.png') no-repeat center;background-size: 90%">
                Look for Sleep Apnea in patients with bradycardia
            </div>
            <div class="w3-col l10 m9 s12 w3-animate-right openSans w3-padding">
                <div class="noMobile" style="height:15vh"></div>
                <ul class="w3-ul" style="font-size: 2.5vmax;font-weight:400;border:#de91a2 solid 0.1vmax;
                padding: 0.5vmax 1vmax">
                    <li>Profound bradycardia can be found in Up to 1/3 of patients with OSA.</li>
                    <li>OSA leads to many CV consequences. </li>
                    <li>Treating OSA reduces arrhythmias and improves CV outcomes.</li>
                    <li class="pinkBg" style="color:#2A1B3d;font-weight: 700">
                        Screening and Treating OSA in patients with bradycardia and in those who already had
                        pacemaker are recommended (class I & IIa).
                    </li>
                </ul>
            </div>
    </div>
        
</div>

<!--LBBB-->
<div class="block w3-white">
    <div id='bigH1' class="bigHeader noMobile" onclick="splitScreen('bigH1','brady1','fChild1')" style="cursor:pointer" title="click me">
        Get an echo <span style="font-weight:400">(at least)</span> <br>for a new LBBB.
        <div style="font-size:2vmax;font-weight:400;line-height:120%;color:#878787">
            click for more...</div>
    </div>
            
    <!--l10 m9 s12-->
    <div id='brady1' class="w3-row w3-padding smallHeader">
                
        <div class="w3-col l10 m9 openSans w3-padding fadeIn">
                <div style="height:50vh" class="w3-center w3-padding">
                    <img src="media/lbbbPrognosis.png" style="max-width:100%;max-height: 100%">
                </div>
                <ul class="w3-ul" style="font-size: 2.5vmax;font-weight:400;border:#de91a2 solid 0.1vmax;
            padding: 0.5vmax">
                    <li class="w3-padding-small">Patients with LBBB have a higher prevalence of both CV and non-CV mortalites. </li>
                    <li class="pinkBg" style="font-weight:700">
                        Transthoracic Echo is recommended (class I) in new LBBB, as well as in high-grade AV block and
                        those whom structural heart diseases are suspected.
                    </li>
                    <li class=" w3-padding-small">Advanced imaging (eg. CT, MRI, or TEE) may be necessary to confirm the diagnosis.</li>
                </ul>


            <div class="ref w3-center">
                <a href="https://www.sciencedirect.com/science/article/pii/000291498190196X?via%3Dihub" 
                target="_blank">
                New LBBB: Framingham Data
                </a>
            </div>
        </div>


        <div id='fChild1' class="w3-col animateBg l2 m3 noMobile w3-center" 
            style="background:url('ringSolidPink.png') no-repeat center;background-size: cover">
            Echo for <br>LBBB</span>
        </div>
            
            
    </div> 


    <!--mobile-->
    <div class="w3-row w3-padding mobileOnly">
        <div class="w3-col s12 mobileOnly bigHeader" 
        style="background:url('ringPink.png') no-repeat center;background-size: 90%">
            Get an echo for a new LBBB.
        </div>  
        <div class="w3-col s12 openSans w3-padding">
                <div class="w3-center w3-padding">
                    <img src="media/lbbbPrognosis.png" style="width:100%;">
                </div>
                <ul class="w3-ul w3-padding" style="font-size: 2.5vmax;font-weight:400;border: #de91a2 solid 0.1vmax;
            padding: 0.5vmax">
                    <li class="w3-padding-small">Patients with LBBB have a higher prevalence of both CV and non-CV mortalites. </li>
                    <li class="acidGreenBg" style="font-weight:700">
                        Transthoracic Echo is recommended (class I) in new LBBB, as well as in high-grade AV block and
                        those whom structural heart diseases are suspected.
                    </li>
                    <li class=" w3-padding-small">Advanced imaging (eg. CT, MRI, or TEE) may be necessary to confirm the diagnosis.</li>
                </ul>


            <div class="ref w3-center">
                <a href="https://www.sciencedirect.com/science/article/pii/000291498190196X?via%3Dihub" 
                target="_blank">
                New LBBB: Framingham Data
                </a>
            </div>
        </div>
    </div>

</div>

<!--SSS-->
<div class="block w3-margin" style="overflow: hidden;">
    <div class="w3-cell-row darkGrey w3-mobile">
      <div class="openSans w3-cell w3-white noMobile" style="font-size:3.2vmax;font-weight:700;line-height: 120%;
      height: 100vh;transform: rotate(10deg);transform-origin: top right;">   
      <div style="transform: rotate(-10deg);padding-left: 5vmax" class="w3-right pink">
      In sinus node dysfunction,<br><span style="color:#2A1B3D">no established<br>PAUSE DURATION</span>
        where PPM is recommended.
      </div>
      </div>   

      <div class="openSans w3-cell w3-white mobileOnly" 
      style="font-size:3.2vmax;font-weight:700;color:#2a1b3d;line-height: 120%;
      padding:2vmax 1vmax;border:#2A1B3D 0.5vh solid">   
      
      In sinus node dysfunction, no established <span class="pink">PAUSE DURATION</span>
        where PPM is recommended.
      
      </div>   
      
      <div class="w3-cell w3-right w3-mobile openSans w3-cell-middle" style="padding:2vmax;color:white;">
        <img src="media/pauseAthletes.png" style="width:100%">
        <div class="ref">
        <a href="https://academic.oup.com/europace/article/18/12/1873/2952220" target="_blank">
        Europace 2016.
        </a></div>
        <br>
        <div class="w3-center" style="font-size:2.8vmax">
        <img src="underlinePink.png" style="width:50%"><br>
        It's all about SYMPTOMS CORRELATION.
        </div>
    </div>
    </div>
</div>
    
<!--bifas-->
<div class="block" style="overflow:hidden">
    <div class="w3-row w3-border">
    <div class="w3-col m4 l4 s12 openSans" style="padding: 8vmax 6vmax 8vmax 2vmax;font-size:3vmax;font-weight: 700;
    background: linear-gradient(-85deg,transparent 25%, #de91a2 25.1%)">
        In conduction disorder<br> (BBB or fascicular block)<br> with syncope, <br><br>
        pacemaker is indicated <br>when...
    </div>
    <div class="w3-col m8 l8 s12 openSans" style="padding: 8vmax 2vmax 2vmax 2vmax">
        <div>
            <img src="media/infraHisianBlk.jpg" style="width:100%">
        </div>
        <ul class="w3-ul w3-padding" style="font-size:3vmax;margin-top: 1vmax">
            <li class="w3-hoverable w3-hover-green">HV &ge;70ms or evidence of infranodal block at EPS.</li>
            <li class="w3-hoverable w3-hover-green">Alternating bundle branch block</li>
            <li class="w3-hoverable w3-hover-yellow">Kearns-Sayre syndrome</li>
        </ul>
    </div>
    </div>
</div>

<!--EP study-->
<div class="block darkGrey">
    <div id='bigH2' class="bigHeader noMobile" onclick="splitScreen('bigH2','brady2','fChild2')"  style="cursor:pointer" title="click me">
        <span class="pink">
        The role of EP Study is quite limited.</span>
        <div style="font-size:2.5vmax;font-weight:400;line-height:120%" class="grey">
        (There's no class I indication...to say the least.)<br>
        <span style="font-size:1.8vmax">
        ...click for more...</span>
        </div>
    </div>
    
    <!--l10 m9 s12-->
    <div id='brady2' class="w3-row w3-padding smallHeader fadeIn" style="padding-top:2vmax;">
        <div id='fChild2' class="w3-col animateBg l2 m3 noMobile w3-center" 
        style="background:url('ringSolidPink.png') no-repeat center;background-size: cover;color:white">
        EP<br>Study</span>
        </div>
        <div class="w3-col l10 m9 s12 openSans w3-padding fadeIn">
            <ul class="w3-ul" style="font-size: 2.8vmax;font-weight:400;border:#a4b3b6  solid 0.1vmax;
            padding: 0.5vmax 1vmax;color:white">
                <li>
                    <div class="w3-row">
                        <div class="w3-cell w3-cell-middle">
                            <img src="media/progressToCHB.png" style="max-width:100%;max-height: 80vh"></div>
                        <div class="w3-cell w3-padding w3-hoverable w3-hover-yellow w3-cell-middle">
                        reasonable in Symptomatic conduction system disease with no demontrated AV block.
                            <div class="ref">
                                <a href="https://linkinghub.elsevier.com/retrieve/pii/0002-9149(82)90469-6">
                                Am J Cardiol 1982.</a>
                            </div>
                        </div>
                    </div>        
                </li>
                <li class="w3-hoverable w3-hover-orange">
                    may consider in SND when other noninvasive tests were unrevealing or 
                    undergoing EPS for other indications.
                </li>
                <li class="w3-hoverable w3-hover-orange">
                    may consider in 2&deg; AVB to determine the level of block and to determine the
                    benefit from pacemaker.
                </li>
                <li class="pinkBg" style="font-weight: 700;color:#2a1b3d">
                    Yield of EP Study depends largely on the patient selection.
                </li>
            </ul>
        </div>
        </div> 

    <!--mobile-->
    <div class="w3-row mobileOnly">
        <div class="w3-col s12 mobileOnly bigHeader"
        style="background:url('ringPink.png') no-repeat center;background-size: 90%">
            <span class="pink">
            The role of EP Study is quite limited.
            </span>
            </div>
            <div class="w3-col l10 m9 s12 openSans w3-padding fadeIn">
                    <ul class="w3-ul" style="font-size: 2.8vmax;font-weight:400;border:#a4b3b6  solid 0.1vmax;
                    padding: 0.5vmax 1vmax;color:white">
                        <li>
                            <div class="w3-row">
                                <div class="w3-cell w3-mobile w3-cell-middle">
                                    <img src="media/progressToCHB.png" style="max-width:100%;max-height: 80vh"></div>
                                <div class="w3-cell w3-mobile w3-padding w3-hoverable w3-hover-yellow w3-cell-middle">
                                reasonable in Symptomatic conduction system disease with no demontrated AV block.
                                    <div class="ref">
                                        <a href="https://linkinghub.elsevier.com/retrieve/pii/0002-9149(82)90469-6">
                                        Am J Cardiol 1982.</a>
                                    </div>
                                </div>
                            </div>        
                        </li>
                        <li class="w3-hoverable w3-hover-orange">
                            may consider in SND when other noninvasive tests were unrevealing or 
                            undergoing EPS for other indications.
                        </li>
                        <li class="w3-hoverable w3-hover-orange">
                            may consider in 2&deg; AVB to determine the level of block and to determine the
                            benefit from pacemaker.
                        </li>
                        <li class="pinkBg" style="font-weight: 700;color:#2a1b3d">
                            Yield of EP Study depends largely on the patient selection.
                        </li>
                    </ul>
                </div>
    </div>
        
</div>

<!--post MI or surgery-->
<div class="block w3-row">
    <!--nonMobile-->
    <div id='hide3' class="w3-cell w3-cell-middle openSans noMobile" 
    style="font-size:4vmax;font-weight:700;line-height: 110%;cursor:pointer;padding: 5vmax 10vmax" title="click me" 
    onclick="hideShowNewRow('hide3','show3')">
        Pacemaker is recommended for new SND or AV block with persistent symptoms that do not RESOLVE after
        the surgery or MI.<br>
        ...<br>
        <span style="color:#555">but how long should we wait for?</span>
        <div style="font-size:2vmax;font-weight:400;line-height:120%" class="grey">
        click for more...
        </div>
    </div>
    <div id='show3' class="w3-row w3-padding openSans shaggyPink fadeIn">
        <div class="w3-cell w3-cell-middle w3-mobile w3-padding">
                <div class="greyBg w3-padding" style="font-size:2.2vmax;font-weight: 700">
                    Most AV block recovered before day 7 after cardiac surgery.
                </div>
            <img src="media/postop.png" style="width:100%">
            
            <div class="ref">
                <a href="https://www.ajconline.org/article/S0002-9149(17)31296-1/fulltext">
                Am J Cardiol 2017.
                </a>
            </div>
        </div>
        <div class="w3-cell w3-mobile w3-padding">
            <table class="w3-table w3-centered openSans w3-bordered w3-border" style="font-size:2.2vmax">
                <tr class="pinkBg">
                    <th class="w3-padding w3-border">Type of Procedures/event</th>
                    <th class="w3-padding">'Reasonable' time to wait</th>
                </tr>
                <tr><td class="w3-border">CABG</td><td>5-7 days</td></tr>
                <tr><td class="w3-border">Aortic Valve Surgery</td><td>3-5 days</td></tr>
                <tr><td class="w3-border">Tricuspid Valve Surgery</td><td>3-5 days</td></tr>
                <tr><td class="w3-border">Mitral Valve Surgery</td><td>5-7 days</td></tr>
                <tr><td class="w3-border">TAVR</td><td>?? 3 days</td></tr>
                <tr><td class="w3-border">Acute MI</td><td>at least 72 hrs.
                    <div class="w3-border-top w3-padding" style="color:#555;font-size:1.8vmax;
                    line-height: 110%;text-align: left">
                    May consider device with defibrillator capacity in patients with low LVEF.
                    </div>
                </td></tr>
            </table>
        </div>
    </div>
</div>

<!--freq RV pacing-->
<div class="block w3-row w3-padding pinkBg">
        <!--nonMobile-->
        <div id='hide4' class="w3-cell w3-cell-middle openSans noMobile" 
        style="font-size:4vmax;font-weight:700;line-height: 110%;cursor:pointer;padding: 5vmax 10vmax" title="click me" 
        onclick="hideShowNewRow('hide4','show4')">
            'PHYSIOLOGIC' pacing is preferred in those with LVEF 36%-50% and those 
            whom frequent RV pacing (>40%) is expected.<br>
            ...<br>
            <span style="color:#555">Physiologic pacing = CRT or His bundle pacing
            </span>
            <div style="font-size:2vmax;font-weight:400;line-height:120%;color:#878787">
            click for more...
            </div>
        </div>
        <div id='show4' class="w3-row w3-padding openSans fadeIn">
            <div style="display:table-cell;vertical-align:middle">
                    
                <img src="media/crtHbp.png" style="width:100%;">
                
                <div style="font-size: 2.5vmax;font-weight:700;">
                    Physiologic pacing (CRT or HBP) have shown a reduction in LVESV and 
                    improvement in LVEF compared with RV pacing.                
                </div>
                <div class="ref">
                    <a href="https://www.sciencedirect.com/science/article/pii/S0735109718389885?via%3Dihub">
                    JACC 2018.
                    </a>
                </div>
        
            </div>
        </div>
</div>

<!--definition: SND, high GR AVB, AF with high Gr AVB, acc junc with va dissoc-->
<div class="block" style="background:radial-gradient(#f2f2f2,white)">
    <div class="w3-row w3-padding openSans w3-right w3-margin" style="font-size:3vmax;font-weight: 700;color:#969696">
        The rest of the guidelines that you already know...
    </div>
    <div class="w3-row openSans pad10LR" style="margin-top: 6vmax">
        <div id='card'>

        </div>
        <div class="w3-center w3-row openSans noMobile" style="font-size:2vmax;padding:1.5vmax;margin-top: 3vmax">
            <span id="bradyWheelLeft" class="w3-btn w3-round-large w3-padding-small">&leftarrow;</span>
            <span id="bradyWheelCenter"></span>
            <span id="bradyWheelRight" class="w3-btn w3-round-large w3-padding-small">&rightarrow;</span><br>
            <span id="autoFwd" title="autoplay on/off" class="w3-btn w3-round-large w3-padding-small w3-border">A</span>
        </div>
    </div>
</div>

<!--AF title-->
<div id='af' class="block blueBg">
        <a href="http://www.onlinejacc.org/guidelines/atrial-fibrillation" target="_blank" style="text-decoration:none">
    <div class="w3-row pad20Center">
            
            <div class="w3-cell openSans w3-center w3-cell-middle" style="background:url('ringSolidDark.png') center no-repeat;background-size: contain;
            font-size:1.8vmax;line-height: 110%;padding: 1vmax;color:white">
                2019<br>ACC/AHA/HRS
            </div>
            <div class="w3-cell openSans w3-padding" style="font-size:5vmax;font-weight:700;line-height: 110%;color:#2a1b3d">
                Atrial Fibrillation Focused Update
            </div>
    </div></a>
    
</div>

<!--nonValvular-->
<div class="block openSans" style="border:#9bb7ee solid 0.5vmax">
    <div id='hide5' class="w3-row blueBg w3-center noMobile pad20Center" 
    style="font-size:6vmax;line-height: 110%;height: 100vh;cursor:pointer" title="click me"  
    onclick="hideShowNewRow('hide5','show5');">
            <span style="font-weight: 700;color:white">Non-valvular AF</span> is now
        
        <div class="w3-row w3-center w3-white" style="font-size: 6vmax;font-weight: 700">
        an outdated term.
        </div>
        <div style="font-size:2vmax;font-weight:400;line-height:120%;color:#555">
        click for more...</div>
    </div>

    <!--mobile-->
    <div id='hide5' class="w3-row blueBg w3-center mobileOnly pad20Center" style="font-size:6vmax;line-height: 110%" >
            <span style="font-weight: 700;color:white">Non-valvular AF</span> is now
        
        <div class="w3-row w3-center w3-white" style="font-size: 6vmax;font-weight: 700">
        an outdated term.
        </div>
    </div>

    <div id='show5' class="w3-row w3-padding">
        
        <div class="w3-cell openSans w3-mobile w3-cell-top"  style="font-size:2.5vmax">
            <ul class="w3-ul">
                <li style="background-color:#dfe6fa">
                    The new term = "MARM-AF", “Mechanical And Rheumatic Mitral valvular AF"
                    is now being proposed.
                </li>
                <li style="background-color:#f1c8cf">
                    NOACs trials consistently excluded those with moderate to severe rheumatic MS and
                    mechanical prosthetic valve.
                </li>
                <li style="background-color:#e7d8f7">
                    High-dose NOACs provide overall efficacy and safety similar in AF patients with or without 
                    VHD (that were not 'MARM').
                </li>
            </ul>
        </div>
        <div class="w3-cell w3-padding w3-mobile w3-cell-middle" style="background:radial-gradient(white,#f1f1f1)">
            <img src="media/VHDNoacs.jpg" style="width:100%">
            <div class="ref">
                <a href="http://www.onlinejacc.org/content/69/11/1363" target="_blank">
                JACC 2017.
                </a>
            </div>
        </div>
    
    </div>
</div>

<!--Sex-->
<div class="block openSans" style="border:#9bb7ee solid 0.5vmax">
    <div id='hide6' class="w3-row blueBg w3-center noMobile pad20Center" 
    style="font-size:6vmax;line-height: 110%;height: 100vh;cursor:pointer" title="click me" 
    onclick="hideShowNewRow('hide6','show6');">The
            <span style="font-weight: 700;color:hotpink">SEXY</span> issue
        
        <div class="w3-row w3-center w3-white" style="font-size: 6vmax;font-weight: 700">
        of the guideline
        </div>
        <div style="font-size:2vmax;font-weight:400;line-height:140%;color:#555">
        click for more...</div>
    </div>

    <!--mobile-->
    <div id='hide6' class="w3-row blueBg w3-center mobileOnly pad20Center openSans" style="font-size:6vmax;line-height: 110%" >
            <span style="font-weight: 700;color:white">The
                <span style="font-weight: 700;color:hotpink">SEXY</span> issue
            
            <div class="w3-row w3-center w3-white" style="font-size: 6vmax;font-weight: 700">
            of the guideline
        </div>
    </div>

    <div id='show6' class="w3-row w3-padding">
        
        <div class="w3-cell w3-padding w3-mobile w3-cell-middle" style="background:radial-gradient(white,#f1f1f1)">
            <img src="media/Sc.png" style="width:100%">
            <div class="ref">
                <a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.029081" target="_blank">
                Circulation 2018.
                </a>
            </div>
        </div>
        <div class="w3-cell openSans w3-mobile w3-cell-top blueBg"  style="font-size:2.5vmax">
            <ul class="w3-ul">
                <li style="background-color:#dfe6fa">
                    Female sex alone does not convey increased risk in 
                    the absence of other factors. <br>
                    Female sex, however, accentuates risk of stroke among those with &ge;2 non-sex related stroke risk factors.
                </li>
                <li class="w3-green">
                    OAC is indicated in AF with an elevated CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 
                    &ge;2 in men or &ge;3 in women.
                </li>
                <li class="w3-yellow">
                    Reasonable to omit OAC in CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 0 in men and 1 in
                    women.
                </li>
            </ul>
        </div>
    
    </div>
</div>

<!--48hrs-->
<div class="block openSans" style="border:#9bb7ee solid 0.5vmax">
    <div id='hide7' class="w3-row blueBg w3-center noMobile pad20Center" 
    style="font-size:6vmax;line-height: 110%;height: 100vh;cursor:pointer" title="click me" 
    onclick="hideShowNewRow('hide7','show7');">
        <img src="media/48hour.gif" style="width:20%;padding:0.2vmax"><br>
        <span style="font-weight:700;">48hr rule still stands.</span><br>
        <span style="font-size:5vmax;color:#2A1B3D;text-align: center">...even with limited data...</span>        
        <div style="font-size:2vmax;font-weight:400;line-height:120%;color:#555">
        click for more...
        </div>    
    
    </div>
    

    <!--mobile-->
    <div id='hide7' class="w3-row blueBg w3-center mobileOnly pad20Center openSans" style="font-size:6vmax;line-height: 110%;">
        <img src="media/48hour.gif" style="width:20%;padding:0.2vmax"><br>
        <span style="font-weight:700;">48hr rule still stands.</span><br>
        <span style="font-size:5vmax;color:#2A1B3D;text-align: center">...even with limited data...</span>        
    </div>
    

    <div id='show7' class="w3-row w3-padding">
        <div class="w3-cell w3-padding-small w3-mobile w3-cell-middle" style="background:radial-gradient(white,#f1f1f1)">
            <img src="media/finCV.png" style="width:100%">
            <div class="w3-row w3-padding openSans w3-border-top" style="line-height: 110%;font-size: 2.2vmax">
                CHA<sub>2</sub>DS<sub>2</sub>-VASc score is a strong predictor of thromboembolic events in 
                cardioversion of acute AF performed without anticoagulation.
            </div>
            <div class="ref">
                <a href="https://www.ajconline.org/article/S0002-9149(16)30146-1/fulltext" target="_blank">
                Am J Cardiol 2016.
                </a>
            </div>
        </div>


        <div class="w3-cell openSans w3-mobile w3-cell-top blueBg"  style="font-size:2.4vmax">
            <ul class="w3-ul" style="line-height: 120%">
                              
                <li class="w3-green">
                    In AF/AFL of <b>48 hrs or unknown duration</b> undergoing cardioversion, 
                    anticoagulation is recommended regardless of CHA<sub>2</sub>DS<sub>2</sub>-VASc score.
                </li>
                <li class="w3-yellow">
                    In AF/AFL of <b>&lt;48 hrs with CHA<sub>2</sub>DS<sub>2</sub>-VASc>2 in men and >3 in women</b> undergoing cardioversion, anticoagulation is reasonable.
                </li>
                <li class="w3-orange">
                    In AF/AFL of <b>&lt;48 hrs with CHA<sub>2</sub>DS<sub>2</sub>-VASc=0 in men and =1 in women</b> undergoing cardioversion, 
                    anticoagulation vs. no anticoagulation may be considered.
                </li>
                <li style="background-color:#dfe6fa">
                    From Fin-CV registry, delay to cardioversion of <b>12 hours</b> from symptom onset was
                    associated with a greater risk of thromboembolic complications compared to cardioversion of 
                    &lt; 12 hours (1.1% versus 0.3%).
                    <div class="ref">
                        <a href="https://jamanetwork.com/journals/jama/fullarticle/1895235" target="_blank">
                        JAMA 2014.</a>
                    </div>     
                </li>
            </ul>
        </div>
            
    </div>
</div>

<!--AF ACS-->
<div class="block darkGrey">
    <div id='bigH3' class="bigHeader noMobile" onclick="splitScreen('bigH3','brady3','fChild3')"
        style="cursor: pointer" title="click me">
        <span class="blue">
        AF complicating ACS.</span>
        <div style="font-size:2.5vmax;font-weight:400;line-height:120%" class="grey">
        ...Triple or double therapy regimens are what you've already heard over the past several years...
        </div>
        <div style="font-size:1.8vmax;font-weight:400;line-height:160%;color:#878787">
        (click for more...)
        </div>

    </div>
    
    <!--l10 m9 s12-->
    <div id='brady3' class="w3-row w3-padding smallHeader fadeIn" style="padding-top:2vmax;">
        <div id='fChild3' class="w3-col animateBg l2 m3 noMobile w3-center" 
        style="background:url('ringSolidBlue.png') no-repeat center;background-size: cover;color:white">
        AF &<br>ACS</span>
        </div>
        <div class="w3-col l10 m9 s12 openSans w3-padding fadeIn">
            <div class="noMobile" style="height:25vh"></div>
            <ul class="w3-ul" style="font-size: 2.8vmax;font-weight:400;border:#a4b3b6  solid 0.1vmax;
            padding: 0.5vmax 1vmax;color:white">
                <li class="w3-hoverable w3-hover-yellow">
                    May choose clopidogrel over prasugrel in triple therapy regimen.
                </li>
                <li class="w3-hoverable w3-hover-yellow">
                    Double therapy with clopidogrel or prasugrel + VKA is reasonable, as compared to triple therapy.
                </li>
                <li class="w3-hoverable w3-hover-yellow">
                    Double therapy with clopidogrel or prasugrel + NOAC (Rivaroxaban 15mg OD or Dabigatran 150 mg BID) 
                    is reasonable, as compared to triple therapy.
                </li>
                <li class="w3-hoverable w3-hover-orange">
                    May switch from triple therapy to double therapy in 4-6 wks after PCI.    
                </li>
            </ul>
        </div>
        </div> 

    <!--mobile-->
    <div class="w3-row mobileOnly">
        <div class="w3-col s12 mobileOnly bigHeader"
        style="background:url('ringBlue.png') no-repeat center;background-size: 90%">
            <span class="blue">
            AF complicating ACS
            </span>
            </div>
            <div class="w3-col l10 m9 s12 openSans w3-padding fadeIn">
                <div class="noMobile" style="height:25vh"></div>
                <ul class="w3-ul" style="font-size: 2.8vmax;font-weight:400;border:#a4b3b6  solid 0.1vmax;
                padding: 0.5vmax 1vmax;color:white">
                    <li class="w3-hoverable w3-hover-yellow">
                        May choose clopidogrel over prasugrel in triple therapy regimen.
                    </li>
                    <li class="w3-hoverable w3-hover-yellow">
                        Double therapy with clopidogrel or prasugrel + VKA is reasonable, as compared to triple therapy.
                    </li>
                    <li class="w3-hoverable w3-hover-yellow">
                        Double therapy with clopidogrel or prasugrel + NOAC (Rivaroxaban 15mg OD or Dabigatran 150 mg BID) 
                        is reasonable, as compared to triple therapy.
                    </li>
                    <li class="w3-hoverable w3-hover-orange">
                        May switch from triple therapy to double therapy in 4-6 wks after PCI.    
                    </li>
                </ul>
            </div>
    </div>
        
</div>

<!--weight loss-->
<div class="block darkGrey">
    <div class="openSans w3-row blue" style="font-size:5vmax;font-weight:700;padding:2vmax;
    line-height: 120%;">
    <div style="padding-left:1vmax">Cut AF Loose</div>
    <div style="padding-left:1vmax;border-bottom: solid black 0.1vmax">by Losing Some Weight.</div>
    </div>
    <div class="w3-row w3-padding w3-margin">
        <div class="w3-cell w3-mobile w3-cell-middle">
        <img src="media/weightLoss.png" style="width:100%;">
            <div class="ref">
                <a href="https://academic.oup.com/europace/article/20/12/1929/5038102" target="_blank">
                REVERSE-AF. Europace 2018.
                </a>
            </div>
        </div>
        <div class="w3-cell w3-mobile w3-padding openSans w3-cell-middle" style="font-size:2.2vmax">
            <ul class="w3-ul">
            <li class="w3-green">
            In AF + BMI>27, weight loss and risk factors modification is recommended.</li>
            <li class="w3-text-white">
                Risk factors = sleep apnea, hypertension, hyperlipidemia, glucose intolerance, and alcohol and tobacco
                use 
            </li>
            </ul>
        </div>
    </div>
</div>

<!--asym-->
<div id='asym' class="block purpleBg">
    <a href="https://academic.oup.com/europace/advance-article/doi/10.1093/europace/euz046/5382236" target="_blank" style="text-decoration:none">
            
    <div class="w3-row pad20Center">
            <div class="w3-cell openSans w3-center w3-cell-middle" style="background:url('ringSolidDark.png') center no-repeat;background-size: contain;
            font-size:1.8vmax;line-height: 110%;padding: 1.5vmax;color:white">
                2019 EHRA Consensus
            </div>
            <div class="w3-cell openSans w3-padding" style="font-size:5vmax;font-weight:700;line-height: 110%;
            color:white">
                Management of asymptomatic arrhythmias
            </div>
    </div></a>
</div>

<!--PAC/PVC-->
<div class="block w3-border">
    <div class="w3-row w3-padding w3-center openSans" 
    style="margin-top:5vmax;font-size: 3vmax;line-height:130%">
        <span style="color:#b48ce6;letter-spacing: 0.8vmax;">asymptomatic</span><br>
        <span style="color:#2A1B3D;font-weight:700;letter-spacing: 0.2vmax;font-size:6vmax">PACs/PVCs</span><br>
        <img src="underlinePurple.png" style="width:50%">
    </div>
    <div class="w3-row w3-padding w3-margin openSans">
        
        <div class="w3-col s4 w3-mobile w3-padding">
            <span style="font-size:5vmax;font-weight: 700;border-bottom:lightpink solid 0.4vmax;margin-left:0.5vmax">500
            <span style="font-size:2vmax">PACs/24hr</span>
            </span>
            <ul class="w3-ul" style="font-size:2.5vmax;text-align: left">
            <li>PACs burden related to higher probability of AF.</li>
            <li>>500 PACs/day: look for AF.</li>
            </ul>
        </div>

        <div class="w3-col s4 w3-mobile w3-padding">
                <span style="font-size:5vmax;font-weight: 700;border-bottom:lightblue solid 0.4vmax;margin-left:0.5vmax">500
                    <span style="font-size:2vmax">PVCs/24hr</span>
                </span>
                <ul class="w3-ul" style="font-size:2.5vmax;text-align: left">
                    <li>>500 PVCs/day: work up for structural heart diseases.</li>
                    <li>Imaging workup includes Echo, MRI, and etc. </li>
                </ul>
            </div>

        <div class="w3-col s4 w3-mobile w3-padding">
                <span style="font-size:5vmax;font-weight: 700;border-bottom:lavender solid 0.4vmax;margin-left:0.5vmax">>10%
                <span style="font-size:2vmax">of PVCs burden</span>
                </span>
                <ul class="w3-ul" style="font-size:2.5vmax;text-align: left">
                <li>Yearly follow-up of LV function.</li>
                <li>Treat underlying disease to improve prognosis.</li>
                <li>Treat PVCs if PVCs mediated cardiomyopathy is suspected.</li>
                </ul>
            </div>
    </div>
        
    
</div>

<!--TICM-->
<div class="block w3-border">
    <div class="w3-row w3-padding w3-center openSans" 
        style="margin-top:1vmax;font-size: 2.5vmax;line-height:120%">
            <span style="color:#b48ce6;letter-spacing: 0.8vmax;">Predictors & Characters</span><br>
            <span style="color:#2A1B3D;font-weight:700;letter-spacing: 0.2vmax;font-size:4vmax">
                Tachycardia induced Cardiomyopathy</span><br>
            <img src="underlinePurple.png" style="width:70%">
    </div>

    <div class="w3-row w3-padding w3-margin openSans">
        
        <div class="w3-col s6 w3-mobile w3-padding">
                <span style="font-size:3vmax;font-weight: 700;border-bottom:lightpink solid 0.4vmax;margin-left:0.5vmax">Characters
                </span>
                <ul class="w3-ul" style="font-size:2.5vmax;text-align: left">
                <li>No other cause of cardiomyopathy (MI, VHD, Htn, alcohol or drug use, stress etc.)</li>
                <li>Absence of LVH. LVEDD &lt; 6.5cm </li>
                <li>Rapid decline in LVEF following recurrence of tachycardia.</li>
                <li>Recovery of LV function after control of tachycardia within a time frame of 1–6 months.</li>
                </ul>
        </div>

        <div class="w3-col s6 w3-mobile w3-padding">
                <span style="font-size:3vmax;font-weight: 700;border-bottom:lightcyan solid 0.4vmax;margin-left:0.5vmax">Predictors
                </span>
                <ul class="w3-ul" style="font-size:2.5vmax;text-align: left">
                <li>Slower tachycardia before cardiomyopathy.</li>
                <li>SVT: incessant, Irregular RR intervals.</li>
                <li>PVCs: burden>10%, wider QRS, interpolated, +retrograde P.</li>
                </ul>
        </div>
    </div>
</div>

<!--VT-->
<div class="block w3-border">
        <div class="w3-row w3-center openSans"
        style="font-size: 3vmax;line-height:130%;padding: 5vmax 1vmax 1vmax 1vmax">
            <span style="color:#b48ce6;letter-spacing: 0.8vmax;">asymptomatic <b>MONOMORPHIC</b></span><br>
            <span style="color:#2A1B3D;font-weight:700;letter-spacing: 0.2vmax;font-size:6vmax">
            ventricular tachycardia</span><br>
            <img src="underlinePurple.png" style="width:70%">
        </div>
        <div class="w3-row w3-center openSans w3-margin pad10LR" style="font-size: 3vmax">
            <div style="background-color:lime;font-weight: 700;letter-spacing: 1vmax">NO Treatment</div>
        if evaluation of structural heart disease with ECHO and Cardiac MRI is normal. <br>
        Need follow-up and LV function monitoring.  
        </div>
    
    </div>

<!--other GL-->
<div class="block" style="background:radial-gradient(#f2f2f2,white)">
    <div class="w3-row w3-padding openSans w3-right w3-margin" style="font-size:3vmax;font-weight: 700;color:#969696">
        One liner from the last-week-released guidelines...
    </div>
    <div class="w3-row openSans" style="margin-top: 6vmax">
        <div class="w3-col s4 w3-mobile sCard" 
        style="background-color:lightpink;transform: rotate(3deg)">
            <a href="https://www.heartrhythmjournal.com/article/S1547-5271(19)30438-2/fulltext" target="_blank"
            style="text-decoration:none">    
            <span class="san" style="font-size:1.7vmax;color: #555;letter-spacing: -0.1vmax;line-height: 110%">
                2019 HRS: Arrhythmogenic Cardiomyopathy</span>
            <div class="w3-margin" style="font-size: 4vmax;font-weight:700;line-height: 110%">
                Anticoagulant therapy is recommended for ARVD, LVNC with AF (I).
            </div>
            </a>

        </div>
        <div class="w3-col s4 w3-mobile sCard" 
        style="background-color:lightblue;transform: rotate(1deg)">
            <a href="https://www.heartrhythmjournal.com/article/S1547-5271(19)30210-3/fulltext"  target="_blank"
            style="text-decoration:none">
            <span class="san" style="font-size:1.7vmax;color: #555;letter-spacing: -0.1vmax;line-height: 110%">
                2019 HRS: Catheter Ablation of VA</span>
            <div class="w3-margin" style="font-size: 3vmax;font-weight:700;line-height: 110%">
                CMR can be useful for risk stratification for sudden cardiac death in patients with frequent PVCs (I).
            </div>
            </a>
        
        </div>

        <div class="w3-col s4 w3-mobile sCard" 
        style="background-color:lavender;transform: rotate(-3deg)">
            <a href="https://www.heartrhythmjournal.com/article/S1547-5271(19)30210-3/fulltext"  target="_blank"
            style="text-decoration:none">
            <span class="san" style="font-size:1.7vmax;color: #555;letter-spacing: -0.1vmax;line-height: 110%">
                2019 HRS: Catheter Ablation of VA</span>
            <div class="w3-margin" style="font-size: 3vmax;font-weight:700;line-height: 110%">
                After less extensive ablation, treatment with antiplatelet for a limited time is reasonable (IIa).
                <br>
                For more extensive ablation, OAC might be reasonable (IIb.)
            </div>
            </a>
        
        </div>
        
        
    </div>
</div>


<!--end pointer-->
</div>

<!--bottom bar-->
<div class="w3-row w3-center san w3-margin" style="font-size: 1.1vmax;color:#868686">
    <a href="https://heartrhythmbox.github.io/main/" target="_blank" style="text-decoration:none">
        <img src="box transparent.png" style="width:1.3vmax">
        HeartRhythmBox: Main Page
    </a> <span style="color:black"> &#9679; </span>
    <a href="#top" style="text-decoration:none;color:black">&uArr; to top</a>
    <span style="color:black"> &#9679; </span>
    <a href="https://www.facebook.com/HeartRhythmBox" style="text-decoration:none" target="_blank">
        <i class="fab fa-facebook-square" style="color:#2E80EC;font-size: 1.2vmax"></i>
        FB: @HeartRhythmBox
    </a>

</div-->

<script src="block navigation.js" ></script>
<script src="pointer.js" ></script>
<script src="wheel.js" ></script>
<script>

//nav and pointer
//up arrow
window.addEventListener("keydown", function(event) {
    event.preventDefault();
    if (event.keyCode===38) {
    blockNav(-1);
    closeMenu();}
})
//down arrow
window.addEventListener("keydown", function(event) {
    event.preventDefault();
    if (event.keyCode===40) {
    blockNav(1);
    closeMenu();}
})

window.addEventListener("keydown", function(event) {
        event.preventDefault();
        if (event.keyCode===80) {
        pointerSwitch()}
    })

window.onscroll = function(){menuReact();
    }

//pointer
var pSwitch = 0;

//ring Row
window.onload = function(){
    if (screen.width<600){
        ringRow(4)
    } else if (screen.width>600 && screen.width<993){
        ringRow(3)
    } else if (screen.width>993) {
        ringRow(2)
    }

    showTxtBlk();autoFwd()
   }

function ringRow(n){
    var width = (screen.width/12)*n
    var ring = document.getElementsByClassName('ring')
    for (var i=0;i<ring.length;i++){
        //vertical center
        var elementH = ring[i].clientHeight;
        var padTop = (width-elementH)/2
        ring[i].style.paddingTop = padTop + 'px'
        //set row height
        ring[i].style.height= width + 'px'
    }

    //horizontal center
    var padN = (12-(n*3))/2;
    var pad = (screen.width/12)*(padN)
    document.getElementById('ringRow').style.marginLeft = pad + 'px'

}


//f9
window.addEventListener("keydown", function(event) {
        event.preventDefault();
        if (event.keyCode===120) {
            showInfo(true)
        }
    })

function showInfo(boolean){
    document.getElementById('author').innerHTML = "Sirin Apiyasawat, MD"
    document.getElementById('title').innerHTML = "Associate Professor" + '</br>' + "Electrophysiology Laboratory"
    +', Ramathibodi Hospital'
     
}

//menu
function menuReact(){
    var menu = document.getElementById('menu');
    var h = (screen.height)/1.25;
    if (document.body.scrollTop > h || document.documentElement.scrollTop > h){
        menu.style.display = 'block'
    } else {
        menu.style.display = 'none';closeMenu();
        
    }
}

var menuStatus = 0;
function openMenu(){
    var h = document.getElementsByClassName('showOnClick')
    var menu = document.getElementById('menu');
    //check menu status
    if (menuStatus==0){
        menuStatus=1;
        menu.style.backgroundColor = 'white';menu.style.opacity = "0.8"
        for (var i=0;i<h.length;i++){
            h[i].style.display ="inline"
        }
    } else {menu.style.backgroundColor = 'transparent';menu.style.opacity = "1"
        closeMenu()
    }
}

function closeMenu(){
    var h = document.getElementsByClassName('showOnClick')  
    menuStatus=0;
        for (var i=0;i<h.length;i++){
            h[i].style.display ="none"
        }
}


function splitScreen(hide,show,child){
    document.getElementById(hide).style.display = "none"
    var show = document.getElementById(show)
    show.style.display = 'block'
    var child = document.getElementById(child)

    //set min-height l2 m3
    var s3 = 3*(screen.width/12);var s2 = 2*(screen.width/12)
    
    if (screen.width>993) {
        child.style.height = s2 + 'px';child.style.paddingTop = 0.2*s2 + 'px';
        child.style.paddingLeft = '2vmax'
    } else if (screen.width>600 && screen.width<993){
        child.style.height = s3 + 'px';child.style.paddingTop = 0.3*s3 + 'px'
        child.style.paddingLeft = '1.5vmax'
    }
}

function hideShowNewRow(hide,show) {
    document.getElementById(hide).style.display = 'none'
    document.getElementById(show).style.display = "block"
    //vertical center for non-mobile
    if (screen.width>600){
        var show =  document.getElementById(show);
        var h = show.offsetHeight;
        var pad = (screen.height-h)/2.5
        show.style.marginTop = pad +'px'
    }
}


</script>
</body>    
</html>
            
